K Number
K230024
Device Name
HI-EMT MAGSHAPE
Date Cleared
2023-09-06

(245 days)

Product Code
Regulation Number
890.5850
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
- Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen. - Strengthening, Toning and Firming of buttocks, thighs and calves. - Improvement of muscle tone and firmness, for strengthening muscles in arms.
Device Description
The proposed device is a type of the most advanced electromagnetic noninvasive treatment machine (with attachments). It is used for muscle tension enhancement and muscle strengthening on abdomen, hips, thighs, arms, etc. Three models (SHE-MSP003, SHE-MSP002 and SHE-MSP001) are included in HI-EMT MAGSHAPE series products, and they have the same intended purposes, working theories and specifications.
More Information

Not Found

No
The document does not mention AI, ML, or any related terms, and the device description focuses on electromagnetic technology for muscle stimulation.

Yes
The device is intended for "improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen," and "strengthening, toning and firming of buttocks, thighs and calves," which are therapeutic effects on the body.

No

The device description and intended use clearly state that it is for muscle strengthening, toning, and firming. There is no mention of it being used to diagnose conditions or diseases.

No

The device description explicitly states it is an "electromagnetic noninvasive treatment machine (with attachments)" and mentions testing against hardware standards (IEC 60601-1, IEC 60601-1-2), indicating it is a physical device, not software-only.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • Device Description and Intended Use: The description and intended use of this device clearly state that it is an electromagnetic noninvasive treatment machine used for muscle tension enhancement and strengthening on various parts of the body (abdomen, hips, thighs, arms, calves, buttocks). It works externally on the body.
  • Lack of Mention of Samples or Testing: There is no mention of collecting or analyzing samples from the body, which is a core characteristic of IVDs.

Therefore, this device falls under the category of a therapeutic or physical medicine device, not an In Vitro Diagnostic.

N/A

Intended Use / Indications for Use

  • Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen.
  • Strengthening, Toning and Firming of buttocks, thighs and calves.
  • Improvement of muscle tone and firmness, for strengthening muscles in arms.

Product codes

NGX

Device Description

The proposed device is a type of the most advanced electromagnetic.noninvasive treatment machine (with attachments). It is used for muscle tension enhancement and muscle strengthening on abdomen, hips, thighs, arms, etc.

Three models (SHE-MSP003, SHE-MSP002 and SHE-MSP001) are included in HI-EMT MAGSHAPE series products, and they have the same intended purposes, working theories and specifications.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Abdomen, buttocks, thighs, calves, arms, hips

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Prescription Use (Part 21 CFR 801 Subpart D)

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Non clinical tests were conducted to verify that the proposed device met all design specifications as was Substantially Equivalent (SE) to the predicate device. The test results demonstrated that the proposed device complies with the following standards:

  • IEC 60601-1 Medical electrical device Part1: General requirements for basic safety and essential performance
  • IEC 60601-1-2 Medical electrical equipment- Part 1-2: General requirements for basic safety and essential performance- Collateral standard: Electromagnetic compatibility- Requirements and tests

No clinical study is included in this submission.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K190456

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 890.5850 Powered muscle stimulator.

(a)
Identification. A powered muscle stimulator is an electrically powered device intended for medical purposes that repeatedly contracts muscles by passing electrical currents through electrodes contacting the affected body area.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

September 6, 2023

Beijing Sano Laser S&T Development Co., Ltd % Heather Wang Consultant Microkn Medical Technology Service (Shanghai) Co.,Ltd. Room 901, No. 889, Pinglu Road, Jing'an District Shanghai (Shanghai Jing'an HUAFA Center) Shanghai, 200435 China

Re: K230024

Trade/Device Name: HI-EMT MAGSHAPE Regulation Number: 21 CFR 890.5850 Regulation Name: Powered Muscle Stimulator Regulatory Class: Class II Product Code: NGX Dated: July 25, 2023 Received: July 25, 2023

Dear Heather Wang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

1

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

Tushar Bansal -S

for Heather Dean, PhD Assistant Director, Acute Injury Devices Team DHT5B: Division of Neuromodulation and Physical Medicine Devices OHT5: Office of Neurological and Physical Medicine Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K230024

Device Name HI-EMT MAGSHAPE

Indications for Use (Describe)

  • · Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen.
  • · Strengthening, Toning and Firming of buttocks, thighs and calves.
  • · Improvement of muscle tone and firmness, for strengthening muscles in arms.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

510(k) Summary K230024

1. Contact information

1.1. Applicant

Applicant Name: Beijing Sano Laser S&T Development Co., Ltd.

Address: Room 7-201, No.1, Caida 3rd Street, Nancai Town, Shunyi

District, Beijing, China.

Contact Person: Hongbo Zhang

Title: Manager

Tel: +86 10 53006037-830

Email: alex(@sanolasers.com

Date prepared: Dec. 15, 2022

1.2. Consultant

Company: Microkn Medical Technology Service (Shanghai) Co.,Ltd.

Address: Room 901, No. 889, Pinglu Road, Jing'an District,

Shanghai (Shanghai Jing'an HUAFA Center)

Contact Person: Heather. Wang

Telephone: +86 13166194697

Email: heather.wang@microkn.com

2. Device information

4

  • Trade Name: HI-EMT MAGSHAPE .
  • Classification Name: Stimulator, Muscle, Powered, for Muscle Conditioning ●
  • Model(s): SHE-MSP003, SHE-MSP002, SHE-MSP001 ●
  • Classification: II ●
  • Product Code: NGX ●
  • Regulation Number: 21 CFR 890.5850 .

3. Indications for Use

  • . Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen.
  • Strengthening, Toning and Firming of buttocks, thighs and calves. ●
  • Improvement of muscle tone and firmness, for strengthening muscles in ● arms.

4. Legally Marketed Predicate Device

Product name: BTL 799-2L

510(k) Number: K190456

Product Code: NGX

Manufacture: BTL Industries, Inc.

5. Description of the device

The proposed device is a type of the most advanced electromagnetic.noninvasive treatment machine (with attachments). It is used for muscle

5

tension enhancement and muscle strengthening on abdomen, hips, thighs, arms, etc.

Three models (SHE-MSP003, SHE-MSP002 and SHE-MSP001) are included in HI-EMT MAGSHAPE series products, and they have the same intended purposes, working theories and specifications.

6

The main components of proposed device shown in Table 1.

ComponentsFunctionsApplied to
HandleDeliver Electromagnetic Field Energy to
Body Part to be TreatedALL Models
Color Touch ScreenUser Interface and System Used for
ControlALL Models
Air SwitchProtect the SystemALL Models
KEY SwitchStart the SystemALL Models

Table 1 Main Components of Proposed Device

6. Non-Clinical Test conclusion

Non clinical tests were conducted to verify that the proposed device met all design specifications as was Substantially Equivalent (SE) to the predicate device. The test results demonstrated that the proposed device complies with the following standards:

  • IEC 60601-1 Medical electrical device Part1: General requirements for ● basic safety and essential performance
  • IEC 60601-1-2 Medical electrical equipment- Part 1-2: General . requirements for basic safety and essential performance- Collateral standard: Electromagnetic compatibility- Requirements and tests

7

7. Clinical Test Conclusion

No clinical study is included in this submission.

8. Substantially Equivalent (SE) Comparison

The HI-EMT MAGSHAPE has been carefully compared to legally marketed devices with respect to intended use, configuration, principle of operation (Table 2), performance specifications (Table 3).

Proposed DevicePredicate Device
ItemHI-EMT
MAGSHAPE
K230024BTL 799-2L
K190456Remark
Product
CodeNGXNGXSame
Regulation
Number21CFR 890.585021 CFR 890.5850Same
Indications
for Use• Improvement of
abdominal tone,
strengthening of the• Improvement of
abdominal tone,
strengthening of theSame
ItemProposed Device
HI-EMT
MAGSHAPEPredicate Device
BTL 799-2LRemark
abdominal muscles,
development of
firmer abdomen.
• Strengthening,
Toning and Firming
of buttocks, thighs
and calves.
• Improvement of
muscle tone and
firmness, for
strengthening
muscles in arms.abdominal muscles,
development of
firmer abdomen.
• Strengthening,
Toning and Firming
of buttocks, thighs
and calves.
• Improvement of
muscle tone and
firmness, for
strengthening
muscles in arms.
Principle of
OperationInitiating action
potential of nerves
results in muscle
contraction.Initiating action
potential of nerves
results in muscle
contraction.Same
Type of usePrescription usePrescription useSame
Proposed DevicePredicate
Device
ItemHI-EMT
MAGSHAPEBTL 799-2LRemark
Electronic Protection
ClassClass I, Type BClass II, Type
BFSimilar
Note 1
User InterfaceTouch screenTouch screenSame
Type of EnergyMagnetic fieldMagnetic fieldSame
Magnetic Field Intensity0-2 TBTL 299-6
applicator:
0.5 - 1.8
T±20%
BTL 299-7
applicator:
0.7 - 2.0
T±20%Similar
Note 2
Pulse Repetition RateF1:1-10Hz
F2:1-100Hz1-150 HzSimilar
Note 2
Pulse Duration300 μsBTL 299-6
applicator:Similar
Note 2
Proposed DevicePredicate
Device
ItemHI-EMT
MAGSHAPEBTL 799-2LRemark
$280 \pm 20% \mu s$
BTL 299-7
applicator:
$190 \pm 20% \mu s$
Selection of
parameters (Intensity,
Time)YesYesSame
Therapy TimeUp to 60 minUp to 60 minSame
Energy SourceAC110V, 60Hz100-240 V AC,
50-60 HzSimilar
Note 1
System Dimensions
(D × W × H)MSP001: 520 *
440 * 1240mm,
Tolerance: ≤ ±
5%
MSP002: 530 *
400* 1140mm,
Tolerance: ≤ ±
5%
MSP003: 550 *580 × 580 ×
1380 mm
(23 × 23 × 55
in)Similar
Note 3
ItemProposed DevicePredicate DeviceRemark
HI-EMT MAGSHAPEBTL 799-2L
400 * 1140mm,
Tolerance: $\leq \pm 5%$
Ambient Temperature+ 16°C ~ + 35°C-10°C ~ +
55°CSimilar
Note 4
Relative Humidity80%, No
Condensation10% to 85%Similar
Note 4
Environmental
SpecificationsFor indoor use
onlyFor indoor use
onlySame

Table 2 General Comparison

8

9

Table 3 Performance Comparison

10

11

Note 1

The proposed device HI-EMT MAGSHAPE has minor difference on Electronic Protection Class and Energy Source with the predicate device BTL 799-2L, but the proposed device had passed IEC 60601-1 and IEC 60601-1-2 test codes, so these differences don't raise any new safety and effectiveness issues.

Note 2

The proposed device HI-EMT MAGSHAPE has differences on stimulation parameter with the predicate device BTL 799-2L. The differences do not raise new question of safety and or effectiveness.

12

Note 3

The proposed device HI-EMT MAGSHAPE has minor difference on System Dimensions with the predicate device BTL 799-2L, but differences on appearance design will not affect the effectiveness and performance of the product and will not increase the risk of the product. So, it doesn't raise any new safety and effectiveness issues.

Note 4

The proposed device HI-EMT MAGSHAPE has minor difference on Ambient Temperature and Relative Humidity with the predicate device BTL 799-2L, but the proposed device had passed the accelerated aging test, so the difference won't raise any new safety and effectiveness issues.

Safety comparison has been done to validate the EMC specification and safety of the device (Table 4).

13

ItemProposed DevicePredicate DeviceRemark
Electrical
safetyComply with IEC
60601-1Comply with IEC
60601-1Same
EMCComply with IEC
60601-1-2Comply with IEC
60601-1-2Same

Biocompatibility Consideration:

The skin contacting element is Acrylonitrile butadiene styrene (ABS). The biocompatibility of the device was assessed in accordance with FDA's 2020 Biocompatibility Guidance "Use of International Standard ISO 10993-1, 'Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process'"

14

9. Substantially Equivalent (SE) Conclusion

Based on the comparison and analysis above, the proposed device is determined to be Substantially Equivalent (SE) to the predicate device.